New research in JAVMA finds dogs with chronic enteropathy are significantly more likely to exhibit anxiety and stress-related behaviors, highlighting a potential gut–brain connection in canine health.
PawCo has introduced PawCo AI, a dog nutrition assistant designed to deliver personalized, veterinary-informed nutrition guidance and product recommendations using artificial intelligence.
The FDA has approved an expanded label for BRAVECTO QUANTUM, adding 12-month protection against Asian longhorned and Gulf Coast ticks in dogs.
Fi has introduced Fi Intelligence™, an AI-powered health companion that leverages behavioral and biometric data to deliver personalized insights into canine health and activity.
Luna remains the most popular puppy name in the United States, while Willow enters the top 10 for the first time, according to Camp Bow Wow’s fifth annual National Puppy Day report.
A new Hill’s Pet Nutrition report finds large dogs experience longer shelter stays and lower adoption rates, driven by concerns around cost, size, and adopter confidence.
Authorization allows veterinarians to use NexGard® and NexGard® COMBO to treat New World screwworm infestations amid spread in Mexico.
Merck Animal Health has received FDA approval for NUMELVI™ (atinvicitinib tablets), the first and only second-generation JAK inhibitor indicated for control of pruritus associated with allergic dermatitis in dogs six months of age and older.
The FDA has conditionally approved Anivive’s Laverdia-CA1 (verdinexor), the first oral SINE-based therapy designed for canine lymphoma, expanding at-home treatment options for both B-cell and T-cell disease.
Loyal has reached a major regulatory milestone as the FDA accepts the Target Animal Safety section for LOY-002, bringing the company closer to launching the first drug intended to extend the healthy lifespan of dogs.